Fairvalue-Calculator Fairvalue-Calculator
EN DE

Careteq Limited (CTQ) Fair Value & Analysis

Healthcare · AU · Market cap A$8.8M

PriceA$0.0130
Fair ValueA$0.0126
Upside-3.0%
Quality95/100
Evidence: Medium Range A$0.0126 – A$0.0126

Fair value as of: Jun 26, 2026

Analysis

Careteq Limited (CTQ) currently trades at A$0.0130, while our model-based Fair Value estimate is A$0.0126 — implying the stock looks roughly 3.0% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Careteq Limited engages in medication management and clinical governance for health, aged, and home care sectors in Australia. The company provides healthcare safety and clinical services. Careteq Limited was incorporated in 2016 and is based in Melbourne, Australia.

Open the full interactive analysis →

Similar stocks

Veeva Systems Inc (VEEV) -35% Pro Medicus Limited (PME) -83% BrightSpring Health Services, Inc (BTSG) -68% Tempus AI, Inc (TEM) -74% HealthEquity, Inc (HQY) -33% M3, Inc (MTHRY) +48%

Frequently asked questions

Is Careteq Limited (CTQ) undervalued?
As of Jun 26, 2026, our model estimates a fair value of A$0.0126 versus a price of A$0.0130 — about −3% (overvalued). Model-based estimate, not financial advice.
What is the fair value of CTQ?
Our 21-model fair value for Careteq Limited is A$0.0126 (as of Jun 26, 2026), built from audited fundamentals. The current price is A$0.0130.
What is the quality score of CTQ?
Careteq Limited has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.